T. A. Os

发表

Indication for CDKN2A Mutation Analysis in Familial Pancreatic Cancer-Families Without Melanomas

E. Kuipers, A. Wagner, P. Fockens, 2011 .

Exploring the link between MORF4L1 and risk of breast cancer

S. Seal, N. Rahman, F. Couch, 2011 .

Epidemiology Ovarian stimulation for IVF and risk of primary breast cancer in BRCA 1 / 2 mutation carriers

J. Oosterwijk, C. J. Asperen, M. Ausems, 2018 .

Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives

E. Dekker, J. Reitsma, F. Nagengast, 2013, Familial Cancer.

Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma

R. Haas, O. Leeksma, A. Rivière, 2015, Annals of Hematology.

Body weight and risk of breast cancer in BRCA1/2 mutation carriers

Maartje J. Hooning, H. Meijers-Heijboer, M. Hooning, 2011, Breast Cancer Research and Treatment.

University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio,

Rensburg, A. Whittemore, D. Steinemann, 2014 .

Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome

P. Devilee, C. Asperen, S. Verhoef, 2016, Human mutation.

ociation of the Variants CASP 8 D 302 H and CASP 10 0 I with Breast and Ovarian Cancer Risk in B & P A 1 and BRCA 2 Mutation Carriers

Rob, T. Rebbeck, J. Benítez, 2010 .

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated

E. Kuipers, Q. Waisfisz, A. Wagner, 2011, European Journal of Human Genetics.

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

K. Czene, P. Hall, V. Pankratz, 2009, Breast Cancer Research and Treatment.

Routine testing for PALB 2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not

E. Kuipers, Q. Waisfisz, A. Wagner, 2012 .

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

C. V. van Asperen, J. Oosterwijk, C. J. Asperen, 2018, British Journal of Cancer.

SNP association study in PMS2-associated Lynch syndrome

E. Steyerberg, A. Wagner, C. Tops, 2017, Familial Cancer.

Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives

E. Dekker, J. Reitsma, F. Nagengast, 2013, Familial Cancer.

Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome

E. Dekker, J. Reitsma, V. Lemmens, 2010, Gut.

Exploring the link between MORF4L1 and risk of breast cancer

S. Seal, N. Rahman, F. Couch, 2011, Breast Cancer Research.

Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas

F. Baas, P. van den Munckhof, I. Christiaans, 2010, Journal of Medical Genetics.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

V. Pankratz, F. Couch, T. Rebbeck, 2011, Human molecular genetics.

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome

J. Houwing-Duistermaat, David Evans, S. Nikolaev, 2019, Genetics in Medicine.